JJournal of Controlled Release3/23/2026Nanospatially confined ROS eliminator produced in situ by engineered Escherichia coli Nissle 1917 for oral treatment of inflammatory bowel diseaseHaoxiang Chen·Lei Ren·Qingxia Shi·Yongtian Zheng·Yanyun Fan·Ziyi Zhang·Jiang WuRead at Journal of Controlled ReleaseTagsCancer Research and TreatmentsBiotechnology
